A phase I study of Iobenguane I 131 to evaluate MTD, efficacy and safety in patients with malignant pheochromocytoma/paraganglioma (Pheo)

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Morse, MA; Babich, JW; LaFrance, N; Kacena, KA; Gockerman, J; Moore, J; Coleman, RE

Published Date

  • May 20, 2008

Published In

Volume / Issue

  • 26 / 15_suppl

Start / End Page

  • 4605 - 4605

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2008.26.15_suppl.4605

Language

  • en